Devices › Device types
FDA product code MSD · class 2 · Gastroenterology, Urology
Catheter, hemodialysis, implanted: medical device reports filed with FDA
11,458 reports carry this product code, 1994–2026; 21 brands with a page.
- 11,458
- reports with this product code
- 0% of all MAUDE reports
- 824
- reports, 12 months to August 2026
- 1,207 in the 12 months before
- 75.8%
- classified as malfunction
- 62.3% across all reports
- 2.6%
- classified as death, as reported
- 0.9% across all reports
Product code MSD is FDA's classification for "Catheter, hemodialysis, implanted" (gastroenterology, Urology panel), a class 2 device. 11,458 medical device reports carry this product code, 0% of the MAUDE database, from August 1994 to August 2026.
824 reports arrived in the 12 months to August 2026, down 32% from 1,207 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (75.8%), injury (20%) and death (2.6%). 21 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Palindrome | 1,402 | 52 | 1.3% | 88.1% |
| GlidePath | 774 | 225 | 0.9% | 89.3% |
| HemoStar | 360 | 84 | 0.8% | 86.1% |
| Lifesite Hemodialysis Access System | 342 | 0 | 6.4% | 9.1% |
| Equistream Split Tip | 295 | 125 | 0% | 85.8% |
| Arrow Hemodialysis Kit 2-L 15 Fr X 19 Cm | 258 | 40 | 0.4% | 97.8% |
| HemoSplit Catheter | 247 | 49 | 1.6% | 76.7% |
| Ash Split Catheter | 172 | 0 | 3.5% | 12.8% |
| Dialysis Unknown | 94 | 6 | 5% | 63.7% |
| Mahurkar | 91 | 6 | 1.1% | 92.4% |
| Angiodynamics / Bioflo | 27 | 0 | 0% | 79.8% |
| Vaxcel Pasv Picc | 3 | 0 | 0.7% | 86.4% |
| Bardia Foley Catheter Silicone Coated | 2 | 193 | 0% | 86.3% |
| AngioDynamics | 1 | 14 | 1.7% | 82.2% |
| Cadd Ms3 Pump | 1 | 0 | 0% | 93.7% |
| Fresenius Dialysis Delivery System | 1 | 0 | 11% | 60.4% |
| Mahurkar Elite | 1 | 10 | 3.3% | 82.2% |
| Minilink Transmitter Transmitter And Sensor Mmt-7002 | 1 | 0 | 0% | 98.9% |
| On-Q Painbuster | 1 | 0 | 0.6% | 4.3% |
| Premicath | 1 | 54 | 3.6% | 69.8% |
| Xmtr MMT-7811NA GST3C Lockout | 1 | 65 | 0% | 99.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| C R Bard Basd -3006260740 | 2,044 | 17.8% |
| Covidien | 1,963 | 17.1% |
| Medcomp | 1,198 | 10.5% |
| Bard Access Systems | 1,169 | 10.2% |
| Covidien Mfg Solutions | 913 | 8% |
| Arrow International | 760 | 6.6% |
| C R Bard Basd | 487 | 4.3% |
| Angiodynamics | 338 | 2.9% |
| Merit Medical Systems | 204 | 1.8% |
| Arrow Intl | 162 | 1.4% |
| C R Bard | 35 | 0.3% |
| Horizon Medical Products | 26 | 0.2% |
| Bard | 6 | 0.1% |
| Boston Scientific | 5 | 0% |
| Fresenius USA | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 1,299 | 11.3% |
| Fluid/blood leak | 1,191 | 10.4% |
| Crackthe device cracked | 1,082 | 9.4% |
| Leak/splashthe device leaked | 989 | 8.6% |
| Explanted | 875 | 7.6% |
| Fracturea broken bone | 772 | 6.7% |
| Deformation due to compressive stress | 468 | 4.1% |
| Material separation | 444 | 3.9% |
| Material deformation | 392 | 3.4% |
| Replace | 384 | 3.4% |
| Defective component | 373 | 3.3% |
| Material puncture/hole | 362 | 3.2% |
| Hole in material | 337 | 2.9% |
| Detachment of device component | 334 | 2.9% |
| Difficult to removethe device was hard to remove | 245 | 2.1% |
| Restricted flow rate | 237 | 2.1% |
| Detachment of device or device componentpart of the device came off | 233 | 2% |
| Migration or expulsion of device | 219 | 1.9% |
| Material opacification | 183 | 1.6% |
| Stretched | 175 | 1.5% |
Questions about catheter, hemodialysis, implanted reports
What is product code MSD?
FDA's classification code for "Catheter, hemodialysis, implanted", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
11,458 reports through August 2026, 824 of them in the latest 12 months.
Which brands appear most often?
Palindrome (1,402), GlidePath (774), HemoStar (360), Lifesite Hemodialysis Access System (342) and Equistream Split Tip (295). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.